Eagle Pharmaceuticals shares are trading lower after the company announced it received notification of deficiency from the Nasdaq regarding the requirement to timely file quarterly report on Form 10-Q. Also, Founder, President and CEO Scott Tarrif...

0.00% Pre

Eagle Pharmaceuticals, Inc.

EGRX

0.00

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.

Recommend

Genius Sports Announces Deal With FanDuel Sports Network To Launch Intelligent Content Platform Across NBA And WNBA

Strattec Security Corporation to Present at Virtual Investor Conferences

Harmony Biosciences To Highlight New Open-Label Extension Data From Its Investigation Of EPX-100 In Ongoing Phase 3 ARGUS Trial For Treatment Of Dravet Syndrome At 2025 AES Annual Meeting

Blackbaud Partners with Anthropic to Launch AI Fundraising Connector for Nonprofits

UPDATE 1-RTX secures $1.6 billion sustainment contract for F135 engines

Equifax Reports Rising Small Business Debt Amid Improved Credit Activity

Pioneer Signs MOU With UEA-Based Savvy Charging Technologies; Terms Not Disclosed

The Long-Awaited Event! Sahm Investment Strategies Summit 2026